The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Outcomes of patients with stage I testicular cancer following orchidectomy with borderline retroperitoneal lymph node enlargement at diagnosis.
 
Deepro Chowdhury
No Relationships to Disclose
 
Eshetu Atenafu
No Relationships to Disclose
 
Di Maria Jiang
Honoraria - Amgen; Astellas Pharma; Astellas Pharma; Astellas Pharma; AstraZeneca; Bayer; Bayer; Bayer; Bayer; EMD Serono; Ipsen; Janssen Oncology; Janssen Oncology; Janssen Oncology; Janssen Oncology; Medunik; Novartis AAA
Consulting or Advisory Role - AstraZeneca/Merck; Bayer; Janssen Oncology; McKesson; Merck; Novartis AAA; Pfizer; Pfizer/EMD Serono; Pfizer/EMD Serono; Pfizer/EMD Serono; Seagen
Research Funding - Amgen; Astellas Pharma (Inst); Bayer; Pfizer; Tersera
Travel, Accommodations, Expenses - Amgen; AstraZeneca; Bayer; EMD Serono; EMD Serono; Pfizer; Pfizer; Pfizer; Pfizer; Roche
 
Esmail Al-Ezzi
No Relationships to Disclose
 
Rachel Glicksman
Honoraria - Bayer; Knight Therapeutics; TerSera; Tolmar
Research Funding - Astellas Pharma (Inst); TerSera (Inst)
 
Peter Chung
Honoraria - Knight Pharmaceuticals; Pfizer; Tersera; Tolmar
Consulting or Advisory Role - EMD Serono; Tersera; Tolmar
Research Funding - Abbvie
 
Susan Prendeville
Honoraria - Pfizer
 
Martin O'Malley
No Relationships to Disclose
 
Padraig Warde
No Relationships to Disclose
 
Robert Hamilton
Honoraria - Astellas Pharma; Bayer; Janssen; Knight Pharmaceuticals; Merck; Novartis; Tersera; Tolmar
Research Funding - Bayer; Janssen; Novartis
Travel, Accommodations, Expenses - Janssen; Tolmar
 
Philippe Bedard
Research Funding - Amgen (Inst); AstraZeneca (Inst); Bayer (Inst); Bicara Therapeutics (Inst); Bristol-Myers Squibb (Inst); Genentech/Roche (Inst); Gilead Sciences (Inst); GlaxoSmithKline (Inst); LegoChem Biosciences (Inst); LegoChem Biosciences (Inst); Lilly (Inst); Medicenna (Inst); Merck (Inst); Novartis (Inst); Sanofi (Inst); Seagen (Inst); Takeda (Inst); Zymeworks (Inst)
(OPTIONAL) Uncompensated Relationships - Janssen Oncology; Lilly; Repare Therapeutics; Roche/Genentech; Seagen; Zymeworks